Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vitamin D as an immune modulator in multiple sclerosis
Halina Bartosik-Psujek, Marek Psujek
Neurologia i Neurochirurgia Polska (2019) Vol. 53, Iss. 2, pp. 113-122
Open Access | Times Cited: 25

Showing 25 citing articles:

Immunomodulatory Effects of Vitamin D in Thyroid Diseases
Chiara Mele, Marina Caputo, Alessandro Bisceglia, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1444-1444
Open Access | Times Cited: 55
Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects
Grace Lassiter, Carlie Melancon, Tyler Rooney, et al.
Neurology International (2020) Vol. 12, Iss. 3, pp. 89-108
Open Access | Times Cited: 42
Comprehensive Stability Study of Vitamin D3 in Aqueous Solutions and Liquid Commercial Products
Žane Temova Rakuša, Mitja Pišlar, Albin Kristl, et al.
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 617-617
Open Access | Times Cited: 36
Covid 19: Diet Composition and Health
Dorota Skrajnowska, Maja Brumer, Sylwia Kankowska, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 2980-2980
Open Access | Times Cited: 31
Role of Fibroblast Growth Factors in Neurological Disorders: Insight into Therapeutic Approaches and Molecular Mechanisms
Shubham Upadhayay, Divya Soni, Maanvi Dhureja, et al.
Molecular Neurobiology (2025)
Closed Access
ROR alpha protects against LPS-induced inflammation by down-regulating SIRT1/NF-kappa B pathway
Shichao Han, Zhenzhen Li, Fu Han, et al.
Archives of Biochemistry and Biophysics (2019) Vol. 668, pp. 1-8
Closed Access | Times Cited: 28
Post-ischemic stroke systemic inflammation: Immunomodulation by progesterone and vitamin D hormone
Fahim Atif, Seema Yousuf, Claudia Espinosa‐García, et al.
Neuropharmacology (2020) Vol. 181, pp. 108327-108327
Closed Access | Times Cited: 20
The effect of calcitriol and all‐trans retinoic acid on T‐bet, IFN‐γ, GATA3 and IL‐4 genes expression in experimental autoimmune encephalomyelitis
Karim Parastouei, Farid Solaymani‐Mohammadi, Mohammad Reza Shiri‐Shahsavar, et al.
Apmis (2020) Vol. 128, Iss. 11, pp. 583-592
Closed Access | Times Cited: 14
Identifying the culprits in neurological autoimmune diseases
Yeny Acosta‐Ampudia, Diana M. Monsalve, Carolina Ramírez‐Santana
Journal of Translational Autoimmunity (2019) Vol. 2, pp. 100015-100015
Open Access | Times Cited: 12
The Influence of Vitamin D on Neurodegeneration and Neurological Disorders: A Rationale for its Physio-pathological Actions
Maria Morello, Massimo Pieri, R Zenobi, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 21, pp. 2475-2491
Closed Access | Times Cited: 12
Association between 25(OH) vitamin D and multiple sclerosis: cohort, shared genetics, and Causality
Xinghao Yu, Huimin Lu, Jun Li, et al.
Nutrition Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis
A. Rasheed, Gulfaraz Khan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity
Susan J. van Rensburg, Ronald van Toorn, Rajiv T. Erasmus, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 6, pp. 1151-1167
Closed Access | Times Cited: 9
Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases
Susan J. van Rensburg, Coenraad Hattingh, Clint Johannes, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 6, pp. 1169-1181
Closed Access | Times Cited: 6
Adequacy and Vitamin D in the Preoperative Period of Roux-en-Y Gastric Bypass, Bariatric Surgery, Can Protect Metabolic Health in Metabolically Healthy and Unhealthy Individuals
Suelem Pereira da Cruz, Sabrina Cruz, Sílvia Pereira, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 402-402
Open Access | Times Cited: 4
25 Hydroxyvitamin D and Cytokine Profile in Patients With Relapsing-Remitting Multiple Sclerosis
G Slavov, Mariya G. Manova, I. Kostadinova
Cureus (2024)
Open Access
Rickets of our time: modern diagnosis and treatment
Ekaterina Pigarova
Meditsinskiy sovet = Medical Council (2020), Iss. 18, pp. 14-20
Open Access | Times Cited: 3
Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors
Zahra Nasr, Akash Virupakshaiah, Vinícius Andreoli Schoeps, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 82, pp. 105351-105351
Closed Access | Times Cited: 1
Further publication enhancements discussed during the current Editorial Board meeting of the Polish Journal of Neurology and Neurosurgery (Neurologia i Neurochirurgia Polska)
Zbigniew K. Wszołek, Łukasz Stolarczyk, Jarosław Sławek
Neurologia i Neurochirurgia Polska (2020) Vol. 54, Iss. 5, pp. 361-363
Open Access | Times Cited: 2
FREQUENCY OF 25-HYDROXY VITAMIN D DEFICIENCY IN PATIENTS WITH MULTIPLE SCLEROSIS
Mehwish Butt, Asma Arman, Mohammed Tahir Ansari
Khyber Medical University Journal (2022) Vol. 14, Iss. 1, pp. 42-46
Open Access | Times Cited: 1
Assessment of 25 (OH) Vitamin D in Neonates with Hypoxic Ischemic Encephalopathy Mohammed Elsayed Hamed 1, Dina Gamal Abd Elhamed 2,
Ansam Mohamed Alshtewi, Nahed Mahmoud Khater, Dina Gamal Abd Elhamed, et al.
The Egyptian Journal of Hospital Medicine (2021) Vol. 85, Iss. 2, pp. 3503-3508
Open Access | Times Cited: 1
Is vitamin D deficiency a reliable risk factor for multiple sclerosis development?
Joanna Tarasiuk, Katarzyna Kapica-Topczewska, Monika Chorąży, et al.
Neurologia i Neurochirurgia Polska (2018)
Open Access
Skin Phototype Could Be a Risk Factor for Multiple Sclerosis
Patricia Urbaneja, Isaac Hurtado-Guerrero, Miguel Ángel Hernández, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2384-2384
Open Access
Influência da imunomodulação da Vitamina D no tratamento complementar da esclerose múltipla / Influence of Vitamin D immunomodulation in the complementary treatment of multiple sclerosis
Rafaela Faiola, Giovanna Sabedotti Tyszka, Jean Carlos Fernando Besson
Brazilian Journal of Development (2022) Vol. 8, Iss. 5, pp. 40497-40515
Open Access
IMPLICATIONS OF VITAMIN D INSUFFICIENCY/DEFICIENCY IN AUTOIMMUNE DISEASES: A REVIEW
Ângela Maria Pereira Alves, Izabela Aparecida Marques Cesilio, Éder Paulo Belato Alves, et al.
Revista Uningá (2021) Vol. 58, pp. eUJ3437-eUJ3437
Open Access
Page 1

Scroll to top